ID   MTA1_RAT                Reviewed;         703 AA.
AC   Q62599; Q9Z0N8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 177.
DE   RecName: Full=Metastasis-associated protein MTA1;
GN   Name=Mta1; Synonyms=Zg29;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Fischer 344; TISSUE=Mammary gland;
RX   PubMed=8083195; DOI=10.1016/s0021-9258(17)31603-4;
RA   Toh Y., Pencil S.D., Nicolson G.L.;
RT   "A novel candidate metastasis-associated gene, mta1, differentially
RT   expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA
RT   cloning, expression, and protein analyses.";
RL   J. Biol. Chem. 269:22958-22963(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Fischer 344; TISSUE=Mammary gland;
RX   PubMed=7607577; DOI=10.1016/0378-1119(94)00410-t;
RA   Toh Y., Pencil S.D., Nicolson G.L.;
RT   "Analysis of the complete sequence of the novel metastasis-associated
RT   candidate gene, mta1, differentially expressed in mammary adenocarcinoma
RT   and breast cancer cell lines.";
RL   Gene 159:97-104(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION (ISOFORMS 1
RP   AND 2), TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Wistar; TISSUE=Pancreas;
RX   PubMed=10393810; DOI=10.1242/jcs.112.15.2539;
RA   Kleene R., Zdzieblo J., Wege K., Kern H.-F.;
RT   "A novel zymogen granule protein (ZG29p) and the nuclear protein MTA1p are
RT   differentially expressed by alternative transcription initiation in
RT   pancreatic acinar cells of the rat.";
RL   J. Cell Sci. 112:2539-2548(1999).
RN   [4]
RP   INTERACTION WITH AMYLASE.
RX   PubMed=10933808; DOI=10.1021/bi000876i;
RA   Kleene R., Classen B., Zdzieblo J., Schrader M.;
RT   "SH3 binding sites of ZG29p mediate an interaction with amylase and are
RT   involved in condensation-sorting in the exocrine rat pancreas.";
RL   Biochemistry 39:9893-9900(2000).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522 AND SER-576, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional coregulator which can act as both a
CC       transcriptional corepressor and coactivator (By similarity). Acts as a
CC       component of the histone deacetylase NuRD complex which participates in
CC       the remodeling of chromatin (By similarity). In the NuRD complex,
CC       regulates transcription of its targets by modifying the acetylation
CC       status of the target chromatin and cofactor accessibility to the target
CC       DNA (By similarity). In conjunction with other components of NuRD, acts
CC       as a transcriptional corepressor of BRCA1, ESR1, TFF1 and CDKN1A (By
CC       similarity). Acts as a transcriptional coactivator of BCAS3, and SUMO2,
CC       independent of the NuRD complex (By similarity). Stimulates the
CC       expression of WNT1 by inhibiting the expression of its transcriptional
CC       corepressor SIX3 (By similarity). Regulates p53-dependent and
CC       -independent DNA repair processes following genotoxic stress (By
CC       similarity). Regulates the stability and function of p53/TP53 by
CC       inhibiting its ubiquitination by COP1 and MDM2 thereby regulating the
CC       p53-dependent DNA repair (By similarity). Plays a role in the
CC       regulation of the circadian clock and is essential for the generation
CC       and maintenance of circadian rhythms under constant light and for
CC       normal entrainment of behavior to light-dark (LD) cycles (By
CC       similarity). Positively regulates the CLOCK-BMAL1 heterodimer mediated
CC       transcriptional activation of its own transcription and the
CC       transcription of CRY1 (By similarity). Regulates deacetylation of BMAL1
CC       by regulating SIRT1 expression, resulting in derepressing CRY1-mediated
CC       transcription repression (By similarity). With TFCP2L1, promotes
CC       establishment and maintenance of pluripotency in embryonic stem cells
CC       (ESCs) and inhibits endoderm differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:Q13330, ECO:0000250|UniProtKB:Q8K4B0}.
CC   -!- SUBUNIT: Component of the nucleosome remodeling and deacetylase (NuRD)
CC       repressor complex, composed of core proteins MTA1, MTA2, MTA3, RBBP4,
CC       RBBP7, HDAC1, HDAC2, MBD2, MBD3, and peripherally associated proteins
CC       CDK2AP1, CDK2AP2, GATAD2A, GATAD2B, CHD3, CHD4 and CHD5 (By
CC       similarity). The exact stoichiometry of the NuRD complex is unknown,
CC       and some subunits such as MBD2 and MBD3, GATAD2A and GATAD2B, and CHD3,
CC       CHD4 and CHD5 define mutually exclusive NuRD complexes (By similarity).
CC       Interacts with RBBP4; the interaction is direct (By similarity).
CC       Interacts with BMAL1. Interacts with CLOCK. Interacts with COP1.
CC       Interacts with CSNK1G2 in the cytoplasm. Interacts with EP300.
CC       Interacts with HDAC2 (By similarity). Interacts with ITGB3BP/CENPR (By
CC       similarity). Interacts with MBD3L2 (By similarity). Interacts with MDM2
CC       (By similarity). Interacts with NACC2 (By similarity). Interacts with
CC       p53/TP53. Interacts with PIAS1. Interacts with PIAS3. Interacts with
CC       PIAS4. Interacts with PWWP2A. Interacts with PWWP2B. Interacts with
CC       SENP1. Interacts with SENP2. Interacts with SIX3; facilitates the
CC       binding of SIX3 to the core DNA motif of SIX3 promoter. Interacts with
CC       SUMO1. Interacts with SUMO2. Interacts with TFCP2L1; which is
CC       indispensable for TFCP2L1-mediated self-renewal-promoting effect and
CC       endoderm-inhibiting action (By similarity). Interacts with TFAP2C (By
CC       similarity). Interacts with TPR. Interacts with UBE2I/UBC9 (By
CC       similarity). {ECO:0000250|UniProtKB:Q13330,
CC       ECO:0000250|UniProtKB:Q8K4B0}.
CC   -!- INTERACTION:
CC       Q62599; Q9ET75: Six3; NbExp=2; IntAct=EBI-349237, EBI-15649593;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus
CC       {ECO:0000269|PubMed:10393810}. Nucleus envelope {ECO:0000255|PROSITE-
CC       ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624}. Cytoplasm
CC       {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associated
CC       with microtubules. Localization at the nuclear envelope is TPR-
CC       dependent (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Rough endoplasmic reticulum
CC       {ECO:0000269|PubMed:10393810}. Golgi apparatus
CC       {ECO:0000269|PubMed:10393810}. Zymogen granule
CC       {ECO:0000269|PubMed:10393810}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=2;
CC       Name=1; Synonyms=MTA1, MTA1p;
CC         IsoId=Q62599-1; Sequence=Displayed;
CC       Name=2; Synonyms=ZG29, ZG29p;
CC         IsoId=Q62599-2; Sequence=VSP_019712, VSP_019713;
CC   -!- TISSUE SPECIFICITY: Isoform 1 abundant in testis and expressed at low
CC       levels in brain, heart, lung, liver, and kidney. Isoform 2 abundant in
CC       adrenal gland, brain, colon, heart, liver, lung, muscle, prostate,
CC       stomach, testis, and thymus and expressed at low levels in duodenum,
CC       kidney, pancreas, parotid, and spleen. {ECO:0000269|PubMed:10393810}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform 1]: Highly expressed in metastatic cells.
CC   -!- INDUCTION: [Isoform 1]: Induced by dexamethasone and, in pancreas, by
CC       treatment with the proteinase inhibitor FOY-305 which binds to
CC       activated trypsin and induces release of cholecystokinin.
CC       {ECO:0000269|PubMed:10393810}.
CC   -!- PTM: Phosphorylation by CSNK1G2/CK1 triggered by estrogen enhances
CC       corepression of estrogen receptor (ER). {ECO:0000250}.
CC   -!- PTM: Acetylation is essential for its transcriptional coactivator
CC       activity. {ECO:0000250}.
CC   -!- PTM: Sumoylation positively regulates its transcriptional corepressor
CC       activity but does not affect the protein stability. Sumoylated
CC       preferentially by SUMO2 or SUMO3 than SUMO1. Sumoylation is enhanced by
CC       PIAS1/3/4 and preferentially sumoylated by SUMO2 in the presence of
CC       PIAS1/3/4. Desumoylated by SENP1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by COP1, which leads to proteasomal degradation.
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Produced by alternative splicing and
CC       alternative initiation at Met-465 of isoform 1. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U02522; AAA82722.1; -; mRNA.
DR   EMBL; AJ132046; CAB38718.1; -; mRNA.
DR   PIR; A54766; A54766.
DR   RefSeq; NP_072110.1; NM_022588.1. [Q62599-1]
DR   AlphaFoldDB; Q62599; -.
DR   SMR; Q62599; -.
DR   BioGRID; 249104; 1.
DR   DIP; DIP-33254N; -.
DR   IntAct; Q62599; 3.
DR   MINT; Q62599; -.
DR   STRING; 10116.ENSRNOP00000006521; -.
DR   iPTMnet; Q62599; -.
DR   PhosphoSitePlus; Q62599; -.
DR   jPOST; Q62599; -.
DR   PaxDb; 10116-ENSRNOP00000051141; -.
DR   GeneID; 64520; -.
DR   KEGG; rno:64520; -.
DR   UCSC; RGD:621018; rat. [Q62599-1]
DR   AGR; RGD:621018; -.
DR   CTD; 9112; -.
DR   RGD; 621018; Mta1.
DR   eggNOG; KOG3554; Eukaryota.
DR   InParanoid; Q62599; -.
DR   OrthoDB; 12566at2759; -.
DR   PhylomeDB; Q62599; -.
DR   Reactome; R-RNO-3214815; HDACs deacetylate histones.
DR   Reactome; R-RNO-3232118; SUMOylation of transcription factors.
DR   Reactome; R-RNO-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-RNO-8943724; Regulation of PTEN gene transcription.
DR   PRO; PR:Q62599; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; ISS:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016581; C:NuRD complex; ISS:UniProtKB.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0042588; C:zymogen granule; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; ISO:RGD.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0045475; P:locomotor rhythm; ISS:UniProtKB.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:1902499; P:positive regulation of protein autoubiquitination; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; ISS:UniProtKB.
DR   GO; GO:0033363; P:secretory granule organization; IDA:UniProtKB.
DR   CDD; cd04709; BAH_MTA; 1.
DR   CDD; cd11661; SANT_MTA3_like; 1.
DR   CDD; cd00202; ZnF_GATA; 1.
DR   Gene3D; 2.30.30.490; -; 1.
DR   Gene3D; 4.10.1240.50; -; 1.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   InterPro; IPR001025; BAH_dom.
DR   InterPro; IPR043151; BAH_sf.
DR   InterPro; IPR000949; ELM2_dom.
DR   InterPro; IPR009057; Homeodomain-like_sf.
DR   InterPro; IPR040138; MIER/MTA.
DR   InterPro; IPR035170; MTA1_R1.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR017884; SANT_dom.
DR   InterPro; IPR000679; Znf_GATA.
DR   PANTHER; PTHR10865; METASTASIS-ASSOCIATED PROTEIN AND MESODERM INDUCTION EARLY RESPONSE PROTEIN; 1.
DR   PANTHER; PTHR10865:SF5; METASTASIS-ASSOCIATED PROTEIN MTA1; 1.
DR   Pfam; PF01426; BAH; 2.
DR   Pfam; PF01448; ELM2; 1.
DR   Pfam; PF00320; GATA; 1.
DR   Pfam; PF17226; MTA_R1; 1.
DR   Pfam; PF00249; Myb_DNA-binding; 1.
DR   SMART; SM00439; BAH; 1.
DR   SMART; SM01189; ELM2; 1.
DR   SMART; SM00717; SANT; 1.
DR   SMART; SM00401; ZnF_GATA; 1.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   PROSITE; PS51038; BAH; 1.
DR   PROSITE; PS51156; ELM2; 1.
DR   PROSITE; PS51293; SANT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative initiation; Alternative splicing;
KW   Biological rhythms; Cytoplasm; Cytoplasmic vesicle; Cytoskeleton;
KW   DNA-binding; Endoplasmic reticulum; Golgi apparatus; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..703
FT                   /note="Metastasis-associated protein MTA1"
FT                   /id="PRO_0000083495"
FT   DOMAIN          1..164
FT                   /note="BAH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00370"
FT   DOMAIN          165..276
FT                   /note="ELM2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00512"
FT   DOMAIN          283..335
FT                   /note="SANT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00624"
FT   ZN_FING         393..420
FT                   /note="GATA-type; atypical"
FT   REGION          437..460
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          542..583
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          644..674
FT                   /note="Interaction with RBBP4"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   REGION          661..703
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           545..552
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           684..693
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           699..703
FT                   /note="SUMO interaction motif 1 (SIM); crucial for
FT                   efficient sumoylation"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        554..583
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         386
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   MOD_RES         449
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   MOD_RES         522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         564
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   MOD_RES         576
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         578
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   MOD_RES         614
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   MOD_RES         627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   CROSSLNK        182
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   CROSSLNK        509
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2 and SUMO3)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        549
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   CROSSLNK        614
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q13330"
FT   VAR_SEQ         1..464
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10393810"
FT                   /id="VSP_019712"
FT   VAR_SEQ         593
FT                   /note="G -> GNMKKRLLMPSRG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10393810"
FT                   /id="VSP_019713"
SQ   SEQUENCE   703 AA;  79412 MW;  F05D8D287C45F13A CRC64;
     MAANMYRVGD YVYFENSSSN PYLIRRIEEL NKTANGNVEA KVVCFYRRRD ISSSLIALAD
     KHATLSVCYR AGPGADTGEE GEVEEEVENP EMVDLPEKLK HQLRHRELFL SRQLESLPAT
     HIRGKCSVTL LNETESLKSY LEREDFFFYS LVYDPQQKTL LADKGEIRVG NRYQADITDL
     LKDGEEDGRD QSKLETKVWE AHNPLVDKQI DQFLVVARSV GTFARALDCS SSVRQPSLHM
     SAAAASRDIT LFHAMDTLHK NIYDISKAIS ALVPQGGPVL CRDEMEEWSA SEANLFEEAL
     EKYGKDFTDI QQDFLPWKSL TSIIEYYYMW KTTDRYVQQK RLKAAEAESK LKQVYIPNYN
     KPNPNQISVN SVKASVVNGT GTPGQSPGAG RACESCYTTQ SYQWYSWGPP NMQCRLCASC
     WTYWKKYGGL KMPTRLDGER PGPNRNNMSP HGIPARSSGS PKFAMKTRQA FYLHTTKLTR
     IARRLCREIL RPWHAARHPY MPINSAAIKA ECTARLPEAS QSPLVLKQVV RKPLEAVLRY
     LETHPRPPKP DPVKSSSSVL SSLTPAKSAP VINNGSPTIL GKRSYEQHNG VDGLANHGQT
     RHMGPSRNLL LNGKSYPTKV RLIRGGSLPP VKRRRMNWID APDDVFYMAT EETRKIRKLL
     SSSETKRAAR RPYKPIALRQ SQALPLRPPP PAPVNDEPIV IED
//
